Innoveren Scientific Inc. · OTC:IVRN
Innoveren Scientific — Medovex — Investor Presentation (June 2015)
18 slides from Innoveren Scientific's investor presentation, Jun 2, 2015
Slide 1: Medovex Corporation
Slide 2: Forward-looking statements disclaimer
to pastinpats in ay iste stetey ad ci spc Slay cre al inp a tifa mi ea pe a upon in connmeton with ay ffex ox rle of secuitin, Ss stain importa inforenition eg not be tne oxo bby mans of « definitive peat placement memecandurnandselated mately including «deed £ dich evey cospectio ive ramned fits bu
Slide 3: Carol's Story
Slide 4: George's Story
Slide 5: Medovex: innovative medical and health care technologies
ug J MEDOVEX At Medovex (MDVX), our goal is to bring innovative medical and health care technologies to the world.
Slide 6: Emerging leader in aggregation of medical and healthcare technologies
= - ‘Modover is an emerging leader in the aggregation of medical and bes pact s NASDAQ: MDVX | ] healthcare technologies. Along with our DenerveX System, we are building through acquisition a diversified portfolio of patented Medtech assets focused on improving the quality of patient care hile posse
Slide 7: Develop and acquire technologies improving patient care
BION AnGloe he MEDOVEX will develop and acquire technologies that significantly improve patient quality of care and health care economics. Initially, we have focused on management of facet joint syndrome and intra-hospital patient transport.
Slide 8: Medical device landscape and competitors
™ 2k MeDIvarion Milieas< ~ENTRE Map pen cane esto "GROUP ‘ A s¢smith&nephew —- Qystommeric a AxigMed ANDREWS {es DARA Bic Arona Mec Ds Boston, & Scientific . Mediironic
Slide 9: Facet joint syndrome (FJS)
aM | Facet joint syndrome (FJS) is a condition in which the joints in the back of the spine degenerate or are injured and subsequently cause pain.
Slide 10: Current Treatment Options
se Current Treatment Options Spinal Injections Radio Frequency Ablation Facet Injections ni = Treatment Effectiveness: Temporary Treatment Effectiveness: Temporary
Slide 11: Two-step procedure with RF Ablation: study of 174 patients
* Using a two-step procedure of facet joint capsular tissue removal and RF Ablation we demonstrated positive outcomes via a study of 174 patients + Inconducting a three to six year follow up it was shown that 73% of the patients were still experiencing positive outcomes Sample Image of the Treated A
Slide 12: DenerveX System
* Combines the two step procedure into one device * Provides for a longer lasting treatment solution * Itis asingle use medical device * Less invasive, minimal recovery time versus surgery * Offers potential savings to the health care system + DenerveX Pro-40 Power Generator precisely matched with t
Slide 13: DenerveX System as long-term treatment solution
SI Temporary Treatments Long Term Treatment A DenerveX System Solution
Slide 14: DenerveX System - Market Size
Slide 15: The Problem / The Solution: Streamline IV Suspension System
ug The Problem The Solution ‘Traditional TV Pump and Equipment Approach ‘Streamline TV Suspension System Approach Safe Easy Efficient
Slide 16: Cumbersome, Current, Unsafe
Cumbersome € Current I Unsafe Medical equipment has become Likelihood of IV line disruption bigger and mo cumbersome and = Umited Geteee Stat he offers significant clinical and the supporting base of equipment transport right now it takes fivandial costs for hospital has not kept pace, as many as 4
Slide 17: The Streamline IV Suspension System - Market Size
Slide 18: Medovex
Medovex NASDAQ: MDVX + Founded by Steve Gorlin (Entremed, Medicis, Medivation, MiMedx) + First developmental product Co-Developed by Dr. Scott Haufe and Dr. James Andrews (world renowned orthopedic surgeon) + Experienced and proven management team and board of directors + Strong balance sheet / No d